| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K80183349 | CTRPv2 | pan-cancer | AAC | 0.0056 | 0.9 |
| mRNA | GSK-650394 | GDSC1000 | pan-cancer | AAC | -0.0062 | 0.9 |
| mRNA | lovastatin | CTRPv2 | pan-cancer | AAC | -0.0063 | 0.9 |
| mRNA | lapatinib | gCSI | pan-cancer | AAC | -0.0094 | 0.9 |
| mRNA | COL-3 | CTRPv2 | pan-cancer | AAC | -0.0063 | 0.9 |
| mRNA | UNC0638 | GDSC1000 | pan-cancer | AAC | -0.0051 | 0.9 |
| mRNA | epigallocatechin-3-monogallate | CTRPv2 | pan-cancer | AAC | -0.006 | 0.9 |
| mRNA | Bortezomib | gCSI | pan-cancer | AAC | 0.01 | 0.9 |
| mRNA | BRD-A05715709 | CTRPv2 | pan-cancer | AAC | 0.0093 | 0.9 |
| mRNA | Erlotinib | FIMM | pan-cancer | AAC | 0.029 | 0.9 |